Neopterin in Acute Coronary Syndrome Patients

February 14, 2022 updated by: Mina Khairy Alyshaa Gorgy, Assiut University
Measurement of neopterin in ACS patients

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

  1. Detect level of neopterin in ACS patients to detect whether there is relation or not between ACS and neopterin
  2. Detection of relation between neopterin and cardiac enzymes as CK and troponine in ACS patients
  3. Detect relation between neopterin level and in hospital events

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Yehia Taha keshik, Prof. Doctor
  • Phone Number: 01223971269

Study Locations

  • Egypt
      • Assiut, Egypt, AssiutU
        • Recruiting
        • Assiut University
        • Contact:
          • Yehia Taha keshik, Prof . Doctor
          • Phone Number: 01223971269
        • Contact:
          • Magdy Ibrahim El desoky, Lecturer
          • Phone Number: 01279950400

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients of sample size admitted to cardiology department with ACS.

Description

Inclusion Criteria:

  • All patient of sample size admitted to cardiology departmentof Assiut university hospital with :

    1. Acute typical chest pain
    2. Positive cardiac enzymes
    3. ECG show recent ischemic changes
    4. ECHO show SWMA

Exclusion Criteria:

  1. Patients not fulfill inclusion criteria.
  2. Patients with other diseases which may cause increase of neopterin level as viral infections, intracellular bacteria or parasites infections, certain malignancies, allograft rejection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To detect whether there is association between neopterin and ACS or not
Time Frame: 72 hours
To detect whether there is association between neopterin and ACS or not
72 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Detection of relation between neopterin and cardiac enzymes as CK and troponine in ACS and detection of relation between neopterin level and in hospital events
Time Frame: 72 hours
Detection of relation between neopterin and cardiac enzymes as CK and troponine in ACS and detection of relation between neopterin level and in hospital events
72 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Investigators

  • Principal Investigator: Magdy Ibrahim Aldesowky, Lecturer, Assiut University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

November 1, 2022

Primary Completion (Anticipated)

October 1, 2023

Study Completion (Anticipated)

October 1, 2024

Study Registration Dates

First Submitted

October 5, 2021

First Submitted That Met QC Criteria

October 5, 2021

First Posted (Actual)

October 15, 2021

Study Record Updates

Last Update Posted (Actual)

February 15, 2022

Last Update Submitted That Met QC Criteria

February 14, 2022

Last Verified

October 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Neopterin

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Share if participants agree

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neopterin in Acute Coronary Syndrome Patients

Clinical Trials on Blood sample

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe